Compare ICUI & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | SXI |
|---|---|---|
| Founded | 1984 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.8B |
| IPO Year | 1992 | N/A |
| Metric | ICUI | SXI |
|---|---|---|
| Price | $145.24 | $246.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $183.60 | ★ $264.00 |
| AVG Volume (30 Days) | ★ 255.1K | 136.1K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.36 |
| Revenue | ★ $2,320,363,000.00 | $837,074,000.00 |
| Revenue This Year | N/A | $15.51 |
| Revenue Next Year | N/A | $7.04 |
| P/E Ratio | ★ N/A | $53.02 |
| Revenue Growth | N/A | ★ 18.51 |
| 52 Week Low | $107.00 | $128.85 |
| 52 Week High | $175.51 | $249.61 |
| Indicator | ICUI | SXI |
|---|---|---|
| Relative Strength Index (RSI) | 61.21 | 60.42 |
| Support Level | $141.10 | $227.57 |
| Resistance Level | $150.38 | $249.61 |
| Average True Range (ATR) | 5.06 | 8.71 |
| MACD | -0.71 | 0.00 |
| Stochastic Oscillator | 64.75 | 93.06 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.